Who are Canna Global?, page-34

Can you show us where this information is Dieter?

MGC Executes JV Agreement for Cosmetics and Medical Products
The JV will be established with a 51% equity interest held by MGC and 49% to be owned by Natura.
The parties will jointly fund the JV’s activities on a pro-rata basis, including outsourcing an R&D team,
laboratory operating costs and the cost of CBD samples.

MGC Signs $60,000,000 Cannabinoids Offtake Agreement
MGC’s has executed a heads of agreement (HOA) with Natura Laboratories Limited (Natura) to supply
a minimum of 300kg of CBD resin extract per year for a minimum of four (4) years. Under the
agreement MGC will supply CBD with a minimum 60% purity making the agreement worth over €40
million (AUD$60 million), and the business is now very confident it will begin generating significant
revenue from Q2/Q3 2016

Nativ Segev, Co-founder and Managing Director, MGC Pharmaceuticals Limited commented:
“We have secured a financially strategic partnership with Natura Laboratories following the execution
of the JV for the research and development of CBD products for the cosmetics and pharmaceutical
industries. This €40,000,000 offtake agreement is of critical importance to MGC and validation of our
business model and industry credentials, and is expected to rapidly accelerate our path to
commercialization and secures our ability to meet or even now exceed our current revenue forecasts.”

Erin Resources, Executive Director Mr. Brett Mitchell said:
“This is a significant commercial milestone for MGC. With the execution of this $60,000,000, 4 year
minimum offtake agreement, which makes MGC the first ASX related vehicle to have secured a major
wholesale supply contract. In conjunction with the license approvals in Slovenia we’re confident that
MGC is on track to meet its initial stated goals both financially and operationally. The board believes
this is a great opportunity for shareholders and I look forward to providing further updates on the
progress of MGC.”

We all do Brett.